Advertisement

Parasomnias and Sleep-Related Movement Disorders in Older Adults

Published:April 22, 2022DOI:https://doi.org/10.1016/j.jsmc.2022.02.005

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Sleep Medicine Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • American Academy of Sleep Medicine
        International classification of sleep disorders.
        3rd edition. American Academy of Sleep Medicine, Darien, IL2014
        • Lecendreux M.
        • Bassetti C.
        • Dauvilliers Y.
        • et al.
        HLA and genetic susceptibility to sleepwalking.
        Mol Psychiatry. 2003; 8: 114-117
        • Heidbreder A.
        • Frauscher B.
        • Mitterling
        • et al.
        Not only sleepwalking but NREM parasomnia irrespective of the type is associated with HLA DQB1∗05:01.
        J Clin Sleep Med. 2016; 12: 565-570
        • Oudiette D.
        • Leu S.
        • Pottier M.
        • et al.
        Dreamlike mentations during sleepwalking and sleep terrors in adults.
        Sleep. 2009; 32: 1621-1627
        • Zadra
        • Desautels A.
        • Petit D.
        • et al.
        Somnambulism: clinical aspects and pathophysiological hypothesis.
        Lancet Neurol. 2013; 12: 185-294
        • Iranzo A.
        • Santamaria J.
        • Tolosa E.
        Idiopathic rapid eye movement sleep behaviour disorder: diagnosis, management, and the need for neuroprotective interventions.
        Lancet Neurol. 2016; 15: 405-419
        • Boeve B.
        REM sleep behaviour disorder. Updated review of the core features, the REM sleep behaviour disorder-neurodegenerative disease association, evolving concepts, controversies, and future directions.
        Ann N.Y Acad Sci. 2010; 1184: 15-54
        • Iranzo A.
        • Lomeña F.
        • Stockner H.
        • et al.
        For the Sleep Innsbruck Barcelona (SINBAR) group. Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study.
        Lancet Neurol. 2010; 9: 1070-1077
        • Postuma R.B.
        • Gagnon J.F.
        • Vendette M.
        • et al.
        Olfaction and color vision identify impending neurodegeneration in rapid eye movement sleep behavior disorder.
        Ann Neurol. 2011; 69: 811-818
        • Iranzo A.
        • Stockner H.
        • Serradell M.
        • et al.
        Five year follow-up of substantia nigra echogenecity in idiopathic REM sleep behavior disorder.
        Mov Disord. 2014; 29: 1774-1780
        • Postuma R.B.
        • Gagnon J.F.
        • Vendette M.
        • et al.
        Markers of neurodegeneration in idiopathic rapid eye movement sleep behavior disorder and Parkinson’s disease.
        Brain. 2009; 13: 3298-3307
        • Iranzo A.
        • Valldeoriola F.
        • Lomeña F.
        • et al.
        Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study.
        Lancet Neurol. 2011; 10: 797-805
        • Fantini M.L.
        • Farini E.
        • Ortelli P.
        Longitudinal study of cognitive function in idiopathic REM sleep behavior disorder.
        Sleep. 2011; 34: 619-625
        • Schenck C.H.
        • Bundlie S.R.
        • Mahowald M.W.
        Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder.
        Neurology. 1996; 46: 388-392
        • Schenck C.H.
        • Boeve B.F.
        • Mahowald M.W.
        Delayed emergence of a parkinsonian disorder or dementia in 81% of older males initially diagnosed with idiopathic REM sleep behavior disorder (IRBD): 16 year update on a previously reported series.
        Sleep Med. 2013; 14: 744-748
        • Iranzo A.
        • Molinuevo J.L.
        • Santamaria J.
        • et al.
        Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disease: a descriptive study.
        Lancet Neurol. 2006; 5: 572-577
        • Iranzo A.
        • Tolosa E.
        • Gelpi E.
        • et al.
        Neurodegenerative status and post-mortem pathology in idiopathic rapid-eye-movement disorder: an observational cohort study.
        Lancet Neurol. 2013; 12: 443-453
        • Iranzo A.
        • Fernández-Arcos A.
        • Tolosa E.
        • et al.
        Neurodegenerative disorder risk in idiopathic REM sleep behavior disorder: study in 174 patients.
        PLoS One. 2014; 9: e89741
        • Postuma R.B.
        • Gagnon J.F.
        • Bertrand J.A.
        • et al.
        Parkinson risk in idiopathic REM sleep behavior disorder: preparing for neuroprotective trials.
        Neurology. 2015; 84: 1104-1113
        • Wing Y.K.
        • Li S.X.
        • Mok V.
        • et al.
        Prospective outcome of rapid eye movement sleep behaviour disorder: psychiatric disorders as a potential early marker of Parkinson's disease.
        J Neurol Neurosurg Psychiatry. 2012; 83: 470-472
        • Youn S.
        • Kim T.
        • Yoon I.Y.
        • et al.
        Progression of cognitive impairments in idiopathic REM sleep behavior disorder.
        J Neurol Neurosurg Psychiatry. 2015; https://doi.org/10.1136/jnnp-2015-311437
        • Postuma R.B.
        • Iranzo A.
        • Hogl B.
        • et al.
        Risk factors for neurodegeneration in idiopathic rapid eye movement sleep behavior disorder: a multicenter study.
        Ann Neurol. 2015; 77: 830-839
        • Sprenger F.S.
        • Stefanova N.
        • Gelpi E.
        • et al.
        Enteric nervous system α-synuclein immunoreactivity in idiopathic REM sleep behavior disorder.
        Neurology. 2015; 85: 1761-1768
        • Vilas D.
        • Iranzo A.
        • Tolosa E.
        • et al.
        Assessment of α-synuclein in submandibular glands of patients with idiopathic rapid-eye-movement sleep behaviour disorder: a case-control study.
        Lancet Neurol. 2016; 15: 708-718
        • Tolosa E.
        • Pont-Sunyer C.
        Progress in defining the premotor phase of Parkinson's disease.
        J Neurol Sci. 2011; 310: 4-8
        • Iranzo A.
        • Gelpi E.
        • Tolosa E.
        • et al.
        Neuropathology of prodromal Lewy body disease.
        Mov Disord. 2014; 29: 410-415
        • Postuma R.N.
        • Lang A.E.
        • Gagnon J.F.
        • et al.
        How does parkinsonism start? Prodromal parkinsonism motor changes in idiopathic REM sleep behaviour disorder.
        Brain. 2012; 27: 617-626
        • Iranzo A.
        • Rye D.B.
        • Santamaria J.
        • et al.
        Characteristics of idiopathic REM sleep behavior disorder and that associated with MSA and PD.
        Neurology. 2005; 65: 247-252
        • Wetter T.C.
        • Trenkwalder C.
        • Gershanik O.
        • et al.
        Polysomnographic measures in Parkinson’s disease: a comparison between patients with and without REM sleep disturbances.
        Wien Klin Wochenschr. 2001; 113: 249-253
        • Gagnon J.F.
        • Vendette M.
        • Postuma R.
        • et al.
        Mild cognitive impairment in rapid eye movement sleep behaviour disorder and Parkinson disease.
        Ann Neurol. 2009; 66: 39-47
        • De Cock V.C.
        • Vidailhet M.
        • Leu S.
        • et al.
        Restoration of normal muscle control in Parkinson’s disease during REM sleep.
        Brain. 2007; 130: 450-456
        • Sixel-Doring F.
        • Trautmann E.
        • Mollenhauer B.
        • et al.
        Associated factors for REM sleep behaviour disorder in Parkinson disease.
        Neurology. 2011; 77: 1048-1054
        • Pont-Sunyer C.
        • Iranzo A.
        • Gaig C.
        • et al.
        Sleep diosrders in parkinsonian and nonparkinsonian LRRK2 mutation carriers.
        PLoS One. 2015; 10: e0132368
        • Wallace D.M.
        • Shafazand S.
        • Carvalho D.Z.
        • et al.
        Sleep-related falling out of bed in Parkinson’s disease.
        J Clin Neurol. 2012; 8: 51-57
        • De Cock V.C.
        • Vidailhet M.
        • Leu S.
        • et al.
        Restoration of normal motor control in Parkinson's disease during REM sleep.
        Brain. 2007; 130: 450-456
        • Plazzi G.
        • Corsini R.
        • Provini F.
        • et al.
        REM sleep behavior disorders in multiple system atrophy.
        Neurology. 1997; 48: 1094-1097
        • De Cock V.
        • Debs R.
        • Oudiette D.
        • et al.
        The improvement of movement of speech during rapid eye movement sleep behavior disorder in multiple system atrophy.
        Brain. 2011; 134: 856-862
        • Palma J.A.
        • Fernandez-Cordon C.
        • Coon E.A.
        • et al.
        Prevalence of REM sleep behavior disorder in multiple system atrophy: a multicenter study and meta-analysis.
        Clin Auton Res. 2015; 25: 69-75
        • Gaig C.
        • Iranzo A.
        • Tolosa E.
        • et al.
        Pathologically description of a non-motor variant of multiple system atrophy.
        J Neurol Neurosurg Psychiatry. 2008; 79: 1399-1400
        • Tachibana N.
        • Kimura K.
        • Kitajama K.
        • et al.
        REM sleep motor dysfunction in multiple system atrophy: with special emphasis on sleep talk as its early clinical manifestation.
        J Neurol Neurosurg Psychiatry. 1997; 63: 678-681
        • McKeith I.G.
        • Dickson D.W.
        • Lowe J.
        • et al.
        Diagnosis and management of dementia with Lewy bodies. Third report of the DLB consortium.
        Neurology. 2005; 65: 1863-1872
        • Boeve B.F.
        • Silber M.H.
        • Ferman T.J.
        • et al.
        REM sleep behavior disorder and degenerative dementia. An association likely reflecting Lewy body disease.
        Neurology. 1998; 51: 363-370
        • Boeve B.F.
        • Silber M.H.
        • Parisi J.E.
        Synucleinopathy pathology and REM sleep behavior disorder plus dementia or parkinsonism.
        Neurology. 2003; 61: 40-45
        • Ferman T.J.
        • Boeve B.F.
        • Smith G.E.
        • et al.
        Inclusion of RBD improves the diagnostic classification of dementia with Lewy bodies.
        Neurology. 2011; 77: 875-882
        • Dugger B.N.
        • Boeve B.F.
        • Murray M.E.
        • et al.
        Rapid eye movement sleep behavior disorder and subtypes in autopsy-confirmed dementia with Lewy bodies.
        Mov Disord. 2012; 27: 72-78
        • Pao W.C.
        • Boeve B.F.
        • Ferman T.J.
        • et al.
        Polysomnographc findings in dementia with Lewy bodies.
        Neurologist. 2013; 19: 1-6
        • Terzaghi M.
        • Arnaldi D.
        • Rizzetti M.C.
        • et al.
        Analysis of video-polysomnographic sleep findings in dementia with Lewy bodies.
        Mov Disord. 2013; 28: 1416-1423
        • Ferman T.J.
        • Smith G.E.
        • Dickson D.W.
        • et al.
        Abnormal daytime sleepiness in dementia with Lewy bodies compared to Alzheimer’s disease using the Multiple Sleep latency Test.
        Alzheimers Res Ther. 2014; 6: 76
        • Ratti P.L.
        • Terzaghi M.
        • Minafra A.
        • et al.
        REM and NREM sleep enactment behaviors in Parkinson’s disease, Parkinson’s disease dementia and dementia with Lewy bodies.
        Sleep Med. 2012; 13: 926-932
        • Dumitrascu O.
        • Schenck C.H.
        • Applebee G.
        • et al.
        Parasomnia overlap disorder: a distinct pathophysiological entity or a variant of rapid eye movement sleep behavior disorder? A case series.
        Sleep Med. 2013; 14: 1217-1220
        • Matos N.
        • Iranzo A.
        • Gaig C.
        • et al.
        Video-polysomnographic documentation of non-rapid eye movement sleep parasomnia followed by rapid eye movement sleep behavior disorder: a parasomnia overlap disorder?.
        Sleep Med. 2016; 23: 46-48
        • Sabater L.
        • Gaig C.
        • Gelpi E.
        • et al.
        A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study.
        Lancet Neurol. 2014; 13: 575-586
        • Gelpi E.
        • Höftberger R.
        • Graus F.
        • et al.
        Neuropathological criteria of anti-IgLON5-related tauopathy.
        Acta Neuropathol. 2016; 132: 531-543
        • Högl B.
        • Heidbreder A.
        • Santamaria J.
        • et al.
        IgLON5 autoimmunity and abnormal behaviours during sleep.
        Lancet. 2015; 385: 1590
        • Simabukuro M.M.
        • Sabater L.
        • Adoni T.
        • et al.
        Sleep disorder, chorea, and dementia associated with IgLON5 antibodies.
        Neurol Neuroimmunol Neuroinflamm. 2015; 2: e136
        • Montojo M.T.
        • Piren V.
        • Benkhadra F.
        • et al.
        Mimicking progressive supranuclear palsy and causing Tako-Tsubo syndrome: a case report on IgLON5 encephalopathy [abstract].
        Mov Disord. 2015; 30: 710
        • Brüggemann N.
        • Wandinger K.P.
        • Gaig C.
        • et al.
        Dystonia, lower limb stiffness, and upward gaze palsy in a patient with IgLON5 antibodies.
        Mov Disord. 2016; 31: 762-764
        • Schröder J.B.
        • Melzer N.
        • Ruck T.
        • et al.
        Isolated dysphagia as initial sign of anti-IgLON5 syndrome.
        Neurol Neuroimmunol Neuroinflamm. 2016; 4: e302
        • Haitao R.
        • Yingmai Y.
        • Yan H.
        • et al.
        Chorea and parkinsonism associated with autoantibodies to IgLON5 and responsive to immunotherapy.
        J Neuroimmunol. 2016; 300: 9-10
        • Zhang W.
        • Niu N.
        • Cui R.
        Serial 18F-FDG PET/CT findings in a patient with IgLON5 encephalopathy.
        Clin Nucl Med. 2016; 41: 787-788
        • Gaig C.
        • Graus F.
        • Compta Y.
        • et al.
        Clinical manifestations of the anti-IgLON5 disease.
        Neurology. 2017; 88: 1736-1743
        • Allen R.P.
        • Picchietti D.L.
        • Garcia-Borreguero D.
        • et al.
        Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria--history, rationale, description, and significance.
        Sleep Med. 2014; 15: 860-873
        • Garcia-Borreguero D.
        • Egatz R.
        • Winkelmann J.
        Epidemiology of restless legs syndrome: the current status.
        Sleep Med Rev. 2006; 10: 153-167
        • Stefansson H.
        • Rye D.
        • Hicks A.
        • et al.
        A genetic risk factor for periodic limb movements in sleep.
        N Engl J Med. 2007; 357: 703-705
        • Winkelmann J.
        • Schormair P.
        • Lichtner P.
        • et al.
        Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions.
        Nat Gen. 2007; 39: 1000-1006
        • Winkelmann J.
        • Schormair B.
        • Xiong L.
        • et al.
        Genetics of restless legs syndrome.
        Sleep Med. 2016; (pii: S1389-9457): 30255-30256
        • Rye D.B.
        Parkinson’s disease and RLS: the dopaminergic bridge.
        Sleep Med. 2004; 5: 317-328
        • Paulus W.
        • Trenkwalder C.
        Less is more: pathophysiology of dopaminergic-therapy-related augmentation in restless legs syndrome.
        Lancet Neurol. 2006; 10: 878-886
        • Winkelman J.W.
        • Armstrong M.J.
        • Allen R.P.
        • et al.
        Practice guideline summary: treatment of restless legs syndrome in adults: report of the guideline development, dissemination, and implementation subcommittee of the American academy of neurology.
        Neurology. 2016; 87: 2585-2593
        • Garcia-Borreguero D.
        • Silber M.H.
        • Winkelman J.W.
        • et al.
        Guidelines for the first-line treatment of restless legs syndrome/Willis-Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundation.
        Sleep Med. 2016; 21: 1-11
        • García-Borreguero D.
        Dopaminergic augmentation in restless legs syndrome/Willis-Ekbom Disease: identification and Management.
        Sleep Med Clin. 2015; 10: 287-292
        • Iber C.
        • Ancoli-Israel S.
        • Chesson A.
        • et al.
        • for the American Academy of Sleep Medicine
        The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications.
        1st edition. American Academy of Sleep Medicine, Westchester, IL2007
        • Pennestri M.H.
        • Whittom S.
        • Adam B.
        • et al.
        PLMS and PLMW in healthy subjects as a function of age: prevalence and interval distribution.
        Sleep. 2006; 29: 1183-1187
        • Gaig C.
        • Iranzo A.
        • Pujo M.
        • et al.
        Periodic limb movements during sleep mimicking REM sleep behavior disorder.
        Sleep. 2016; (pii: sp-00337-16. [Epub ahead of print])
        • Iranzo A.
        • Santamaría J.
        Severe obstructive sleep apnea mimicking REM sleep behavior disorder.
        Sleep. 2005; 28: 203-206
        • Iranzo A
        • Borrego S.
        • Vilaseca I.
        • et al.
        a-Synuclein aggregates in labial salivary glands of idiopathic rapid eye movement sleep behavior disorder.
        Sleep. 2018; 41
        • Fernández-Arcos A.
        • Vilaseca I.
        • Aldecoa I.
        • et al.
        Alpha-synuclein aggregates in the parotid gland of idiopathic REM sleep behavior disorder.
        Sleep Med. 2018; 52: 14-17
        • Antelmi E
        • Donadio V.
        • Incensi A.
        • et al.
        Skin nerve phosphorylated a-synuclein deposits in idiopathic REM sleep behavior disorder.
        Neurology. 2017; 88: 2128-2131
        • Doppler K.
        • Jentschke H.M.
        • Schulmeyer L.
        • et al.
        Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson’s disease.
        Acta Neuropathol. 2017; 133: 535-545
        • Stefani A
        • Iranzo A.
        • Holzknecht E.
        • et al.
        Alpha-synuclein seeds in olfactory mucosa of patients with isolated rapid-eye-movement sleep behaviour disorder.
        Brain. 2021; 144: 1118-1126
        • Iranzo A
        • Fairfoul G.
        • Ayudhay N.
        • et al.
        Cerebrospinal fluid alpha-synuclein detection by RT-QuIC in patients with isolated REM sleep behavior disorder.
        Lancet Neurol. 2021; 20: 203-212